ELAN VS XRAY Stock Comparison

PerformanceAnalyst Price TargetsTechnicalsEarningsProfitVolatilityDividend
PerformanceAnalyst Price TargetsTechnicalsEarningsProfitVolatilityDividend

Performance

ELAN
10/100

ELAN returned -9.80% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

XRAY
10/100

XRAY returned -6.48% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

Analyst Price Targets

ELAN
64/100

11 analysts offer 12-month price targets for ELAN. Together, they have an average target of 27, the most optimistic target put ELAN at 37 within 12-months and the most pessimistic has ELAN at 18.

XRAY
73/100

13 analysts offer 12-month price targets for XRAY. Together, they have an average target of 49.71, the most optimistic target put XRAY at 60 within 12-months and the most pessimistic has XRAY at 46.

Technicals

ELAN
89/100

ELAN receives a 89 of 100 based on 14 indicators. 12 are bullish, 1 are bearish.

XRAY
36/100

XRAY receives a 35 of 100 based on 14 indicators. 4 are bullish, 8 are bearish.

Earnings

ELAN
100/100

ELAN has missed earnings 1 times in the last 20 quarters.

XRAY
31/100

XRAY has missed earnings 4 times in the last 20 quarters.

Profit

ELAN
22/100

Out of the last 20 quarters, ELAN has had 6 profitable quarters and has increased their profits year over year on 2 of them.

XRAY
49/100

Out of the last 20 quarters, XRAY has had 14 profitable quarters and has increased their profits year over year on 5 of them.

Volatility

ELAN
45/100

ELAN has had a lower than average amount of volatility over the last 12 months giving it a score of 44 of 100.

XRAY
48/100

XRAY has had a lower than average amount of volatility over the last 12 months giving it a score of 48 of 100.

Dividend

ELAN

"Dividend" not found for ELAN

XRAY
10/100

XRAY's most recent dividend was $0.09 per share, based on a share price of $29.32. It was a payout ratio of 1,083.33% compared to their total earnings.

All score calculations are broken down here to help you make more informed investing decisions

Elanco Animal Health Incorporated Common Stock Summary

New York Stock Exchange / ELAN
Healthcare
Drug Manufacturers - Specialty & Generic
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

DENTSPLY SIRONA Inc. Summary

Nasdaq / XRAY
Healthcare
Medical - Instruments & Supplies
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.